HDAC-1 inhibitors (Shanghai Institute of Pharmaceutical Industry)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameHDAC-1 inhibitors (Shanghai Institute of Pharmaceutical Industry)
Drug Alias Namechidamide derivatives (Shanghai Institute of Pharmaceutical Industry)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 1 degraders
TargetsHistone deacetylase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A